REAL-WORLD EFFECTIVENESS AND RACIAL/ETHNIC DISPARITIES IN IMMUNOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA: ANALYSIS OF US NATIONAL CANCER DATABASE

被引:0
|
作者
Ahn, Joseph C.
Lauzon, Marie
Luu, Michael
Noureddin, Mazen
Ayoub, Walid S.
Kuo, Alexander
Sundaram, Vinay
Kosari, Kambiz
Nissen, Nicholas N.
Gong, Jun
Hendifar, Andrew
Roberts, Lewis R.
Abou-Alfa, Ghassan K.
Singal, Amit G.
Yang, Ju Dong
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
950
引用
收藏
页码:S1140 / S1140
页数:1
相关论文
共 50 条
  • [41] Racial Disparities and Standard Treatment in Locally Advanced Rectal Cancer: A National Cancer Database Study
    Vassantachart, April
    Marietta, Michael
    Mehta, Shahil
    Lin, Eugene
    Bian, Shelly
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S30 - S30
  • [42] Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases
    Minhas, Abdul Mannan Khan
    Talha, Khawaja M.
    Abramov, Dmitry
    Johnson, Heather M.
    Antoine, Steve
    Rodriguez, Fatima
    Fudim, Marat
    Michos, Erin D.
    Misra, Arunima
    Abushamat, Layla
    Nambi, Vijay
    Fonarow, Gregg C.
    Ballantyne, Christie M.
    Virani, Salim S.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2024, 116 (03) : 258 - 270
  • [43] TREATMENT PATTERNS AND IMMUNOTHERAPY RECHALLENGE IN ADVANCED OR METASTATIC UPPER GASTROINTESTINAL CANCER IN A US REAL-WORLD SETTING
    Ajani, Jaffer
    Boyd, Marley
    Wogen, Jenifer
    Ferrusi, Ilia
    Nakhaei, Peyman
    Menon-Singh, Lakshmi
    Fagan, Ailis
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A465 - A465
  • [44] A real-world analysis of survival and cost-effectiveness of sintilimab plus bevacizumab biosimilar regimen in patients with advanced hepatocellular carcinoma
    Xianghua Zeng
    Yingxin Jia
    Hongmei Chen
    Qinli Luo
    Huakan Zhao
    Guanzhong Liang
    Wen Chen
    Yongsheng Li
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 9213 - 9219
  • [45] A real-world analysis of survival and cost-effectiveness of sintilimab plus bevacizumab biosimilar regimen in patients with advanced hepatocellular carcinoma
    Zeng, Xianghua
    Jia, Yingxin
    Chen, Hongmei
    Luo, Qinli
    Zhao, Huakan
    Liang, Guanzhong
    Chen, Wen
    Li, Yongsheng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 9213 - 9219
  • [46] Impact of etiology of hepatocellular carcinoma on treatment outcomes in a real-world database.
    Brown, Timothy J.
    Mamtani, Ronac
    Gimotty, Phyllis A.
    Karasic, Thomas Benjamin
    Yang, Yu-Xiao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 508 - 508
  • [47] Utility of adjuvant immunotherapy in high-risk non-metastatic renal cell carcinoma: A real-world experience using national cancer database analysis
    Garg, H.
    Bhandari, M.
    Noel, O. V.
    Dursun, F.
    Liss, M. A.
    Kaushik, D.
    Ramamurthy, C.
    Mansour, A. M.
    EUROPEAN UROLOGY, 2023, 83 : S678 - S679
  • [49] Trends in primary treatment of advanced ovarian cancer: A real world national database analysis
    Craig, Amaranta
    Deng, Mengying
    Handorf, Elizabeth
    Mantia-Smaldone, Gina
    Chu, Christina
    Ray, Jocelyn
    Huelsmann, Erica
    Jain, Angela
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S173 - S173
  • [50] Ethnic and Racial Disparities in Delay of Definitive Chemoradiation for Anal Cancer: A National Analysis
    Ramey, S. J.
    Kwon, D.
    Mellon, E. A., Jr.
    Wolfson, A. H.
    Portelance, L.
    Yechieli, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E412 - E412